Back to top

Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)

Truist Financial analyst David S Macdonald maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $1...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quest Diagnostics Incorporated (DGX)